Through
11/26
Perelman School of Medicine
Workplace pumping made easier
Workplace pumping made easier
Listening to employee feedback, Penn Medicine added hospital-grade pumps and doubled its lactation spaces, taking strides to help women meet their breastfeeding goals.
Why we have hair here, but not there
Why we have hair here, but not there
A new study answers a fundamental question in human evolution about how and where hair grows on the body, and reveals the existence of a naturally-occurring inhibitor to hair growth.
Treating spinal pain with ‘engineered living tissue’ moves closer to reality
Treating spinal pain with ‘engineered living tissue’ moves closer to reality
A multidisciplinary team at Penn successfully demonstrated the feasibility of an innovative new disc replacement made of living material.
World AIDS Day: What’s happening with the epidemic today
World AIDS Day: What’s happening with the epidemic today
Professor of Medicine and Associate Chief of the Infectious Diseases Division Ian Frank explains progress made and challenges still faced in the world of HIV/AIDS research, prevention, and treatment.
FDA approves new targeted drug for leukemia
FDA approves new targeted drug for leukemia
The drug is the first to target common mutations associated with relapse and short survival in acute myeloid leukemia.
A link between anti-malaria drugs and cancer treatments, explained
A link between anti-malaria drugs and cancer treatments, explained
The Abramson Cancer Center study is the first to identify what drugs known as chloroquines are targeting when used for cancer treatment.
Modeling the most common form of vision loss in older adults
Modeling the most common form of vision loss in older adults
Age-related macular degeneration is the leading cause of vision loss in people older than 50. Kathleen Boesze-Battaglia and colleagues have developed a model system that mimics many features of the human condition, giving scientists a platform to gain a deeper understanding of risk factors and possible treatments.
The Power of Penn in London
The Power of Penn in London
In London, President Amy Gutmann presented the vision for the University’s $4.1 billion campaign, The Power of Penn.
Racial disparities in sudden cardiac death rates cannot be explained by known risk factors
Racial disparities in sudden cardiac death rates cannot be explained by known risk factors
Despite controlling for factors including income, smoking, and cholesterol levels, black patients remain at high risk.
The ‘immunorevolution’ has begun
The ‘immunorevolution’ has begun
Penn Medicine experts gathered for a panel discussion about their innovative new approach to harness the body’s own immune system to fight cancer.
In the News
Philadelphia Inquirer
Is there a chemical link to memory loss? Penn researchers get $11M to study dementia causes
The National Institutes of Health have awarded $11 million to Aimin Chen of the Perelman School of Medicine to study the link between chemical exposures and dementia.
FULL STORY →
Philadelphia Inquirer
COVID patient who survived coma reunites with Penn care team
A COVID patient who survived his coma recently reunited with the Penn Medicine care team that helped save his life, including Jennifer Olenik of the Perelman School of Medicine.
FULL STORY →
CNN
Vaping immediately affects vascular health and oxygen levels, study shows, even without nicotine
Research published by Marianne Nabbout while a resident at the Perelman School of Medicine finds that vaping has an immediate effect on blood vessels even if an e-cigarette doesn’t contain nicotine.
FULL STORY →
Fox 29 (Philadelphia)
Former patient gives thanks to PA hospital staff after surviving coma, COVID-19 battle
A former COVID patient who spent six months in a coma returned to thank the Penn Medicine team that contributed to his survival, including Megan Carr-Lettieri.
FULL STORY →
Forbes
Insomnia may be more common than you think. Here’s what to know
According to Penn Medicine, about 1 in 4 Americans experiences difficulty with sleep each year.
FULL STORY →